The authors report the first magnetic resonance (MR) images produced by their prototype MR system integrated with a radiation therapy source. The prototype consists of a 6 MV linac mounted onto the open end of a biplanar 0.2 T permanent MR system which has 27.9 cm pole-to-pole opening with flat gradients (40 mT/m) running under a TMX NRC console. The distance from the magnet isocenter to the linac target is 80 cm. The authors' design has resolved the mutual interferences between the two devices such that the MR magnetic field does not interfere with the trajectory of the electron in the linac waveguide, and the radiofrequency (RF) signals from each system do not interfere with the operation of the other system. Magnetic and RF shielding calculations were performed and confirmed with appropriate measurements. The prototype is currently on a fixed gantry; however, in the very near future, the linac and MR magnet will rotate in unison such that the linac is always aimed through the opening in the biplanar magnet. MR imaging was found to be fully operational during linac irradiation and proven by imaging a phantom with conventional gradient echo sequences. Except for small changes in SNR, MR images produced during irradiation were visually and quantitatively very similar to those taken with the linac turned off. This prototype system provides proof of concept that the design has decreased the mutual interferences sufficiently to allow the development of real-time MR-guided radiotherapy. Low field-strength systems (0.2-0.5 T) have been used clinically as diagnostic tools. The task of the linac-MR system is, however, to provide MR guidance to the radiotherapy beam. Therefore, the 0.2 T field strength would provide adequate image quality for this purpose and, with the addition of fast imaging techniques, has the potential to provide 4D soft-tissue visualization not presently available in image-guided radiotherapy systems. The authors' initial design incorporates a permanent magnet; however, other types of magnets and field strengths could also be incorporated. Usable MR images were obtained during linac irradiation from the linac-MR prototype. The authors' prototype design can be used as the functional starting point in developing real-time MR guidance offering soft-tissue contrast that can be coupled with tumor tracking for real-time adaptive radiotherapy.
The susceptibility distortions were quantified as a function of multiple parameters such as the χ inhomogeneity size and shape, the magnitude of B(0) and the readout gradient, and the orientation of B(0) with respect to the sample geometry. The analysis was performed for several anatomical sites and corresponding to two B(0) orientations as featured by MR-linac systems.
A novel geometry has been proposed for a hybrid magnetic resonance imaging (MRI)-linac system in which a 6 MV linac is mounted on the open end of a biplanar, low field (0.2 T) MRI magnet on a single gantry that is free to rotate around the patient. This geometry creates a scenario in which the magnetic field vector remains fixed with respect to the incident photon beam, but moves with respect to the patient as the gantry rotates. Other proposed geometries are characterized by a radiation source rotating about a fixed cylindrical magnet where the magnetic field vector remains fixed with respect to the patient. In this investigation we simulate the inherent dose distribution patterns within the two MRI-radiation source geometries using PENELOPE and EGSnrc Monte Carlo radiation transport codes with algorithms implemented to account for the magnetic field deflection of charged particles. Simulations are performed in phantoms and for clinically realistic situations. The novel geometry results in a net Lorentz force that remains fixed with respect to the patient (in the cranial-caudal direction) and results in a cumulative influence on dose distribution for a multiple beam treatment scenario. For a case where patient anatomy is reasonably homogeneous (brain plan), differences in dose compared to a conventional (no magnetic field) case are minimal for the novel geometry. In the case of a lung plan where the inhomogeneous patient anatomy allows for the magnetic field to have significant influence on charged particle transport, larger differences occur in a predictable manner. For a system using a fixed cylindrical geometry and higher magnetic field (1.5 T), differences from the case without a magnetic field are significantly greater.
The aim of this study is to develop a magnetic resonance imaging (MRI)-based treatment planning procedure for intracranial lesions. The method relies on (a) distortion correction of raw magnetic resonance (MR) images by using an adaptive thresholding and iterative technique, (b) autosegmentation of head structures relevant to dosimetric calculations (scalp, bone and brain) using an atlas-based software and (c) conversion of MR images into computed tomography (CT)-like images by assigning bulk CT values to organ contours and dose calculations performed in Eclipse (Philips Medical Systems). Standard CT + MRI-based and MRI-only plans were compared by means of isodose distributions, dose volume histograms and several dosimetric parameters. The plans were also ranked by using a tumor control probability (TCP)-based technique for heterogeneous irradiation, which is independent of radiobiological parameters. For our 3 T Intera MRI scanner (Philips Medical Systems), we determined that the total maximum image distortion corresponding to a typical brain study was about 4 mm. The CT + MRI and MRI-only plans were found to be in good agreement for all patients investigated. Following our clinical criteria, the TCP-based ranking tool shows no significant difference between the two types of plans. This indicates that the proposed MRI-based treatment planning procedure is suitable for the radiotherapy of intracranial lesions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.